ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

CARA Platform Gains Global Momentum as Generis Unlocks Record Implementation Speeds

By: PRLog
AI-powered CARA Platform and new Starter Pack Model fuel rapid expansion across regulated sectors

LONDON - July 3, 2025 - PRLog -- Generis, creator of the CARA Platform and CARA Life Sciences Platform, is continuing to accelerate its momentum across both Life Sciences and a growing portfolio of other highly regulated industries. Known for its deep expertise in content and information management, the company is now seeing a strong uptick in organisations looking to replace legacy systems like Documentum with CARA – not only in Life Sciences but also in Financial Services, Automotive, Engineering, the Public Sector and more.

In Life Sciences, Generis has strengthened its position with the launch of a new Starter Package, designed to make the industry-leading CARA Life Sciences Platform more accessible to emerging enterprises. The package combines a simplified architecture for competitive pricing with the full power of the CARA Platform, enabling rapid implementation without compromising on quality or functionality. The offering has already resonated with emerging biotech and mid-sized pharma organisations, who are eager to adopt a scalable platform that grows with them.

"From day one, our mission has been to provide the best technology and user experience to manage not just documents but also data and business processes," said Max Kelleher, CEO of Generis. "This latest momentum confirms that CARA is not just the platform of choice for enterprise-scale Life Sciences companies – it's now also the most accessible and effective solution for companies of all sizes looking to digitally transform their company-wide workflows."

Beyond Life Sciences, Generis is expanding its footprint in sectors that demand the same levels of rigour, compliance, and adaptability. The CARA Platform is increasingly selected by automotive, financial services, and engineering firms, as well as public sector organisations, as they seek modern, flexible alternatives to legacy document and content management systems. This surge in adoption is reflected in growing global demand, as organisations transition away from fragmented solutions towards a unified, configurable platform.

Supporting this cross-industry growth is the launch of a new Generis website (www.generiscorp.com), which provides tailored content and use cases for organisations beyond Life Sciences, showcasing how CARA delivers value in a wide range of regulated environments.

Meanwhile, Generis continues to push innovation forward with CARA AI, released in March 2025. The first release includes AI assisted search, a powerful capability that enables users to retrieve documents, data, and answers quickly with natural language.  In addition, users can also create document summaries, and compare, translate, and generate documents with a simple prompt. The company's AI roadmap will continue to expand, transforming how users interact with and gain insight from their enterprise information.

"Our growth across industries and regions is being driven by a clear demand for modern platforms that are smarter, faster, and more intuitive," added Max Kelleher. "CARA continues to lead because it's the only solution that combines deep domain capability with a truly configurable, AI-enhanced user experience."

To learn more about the CARA Platform and explore solutions for your industry, visit www.generiscorp.com.

Contact
Generis
***@generiscorp.com

Photos: (Click photo to enlarge)

Generis Logo Momentum Pr 2025


Source: Generis

Read Full Story - CARA Platform Gains Global Momentum as Generis Unlocks Record Implementation Speeds | More news from this source

Press release distribution by PRLog
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.